Evidence map›Paper›PMID 35191221›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Interleukin-6 potentiates endurance training adaptation and improves functional capacity in old mice.

Aurel B Leuchtmann, Regula Furrer, Stefan A Steurer, Konstantin Schneider-Heieck, Bettina Karrer-Cardel, Yves Sagot, Christoph Handschin

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Impaired age-associated mitochondrial translation is mitigated by exercise and PGC-1α.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Muscle-Brain crosstalk in cognitive impairment.Frontiers in aging neuroscience · 2023
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aurel B LeuchtmannBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-5800-005X
Regula FurrerBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0003-1732-1110
Stefan A SteurerBiozentrum, University of Basel, Basel, Switzerland.
Konstantin Schneider-HeieckBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0001-8158-9424
Bettina Karrer-CardelBiozentrum, University of Basel, Basel, Switzerland.
Yves SagotSonnet Biotherapeutics CH SA, Geneva, Switzerland.
Christoph HandschinBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0003-0603-1097
University of Basel · CHCharles Humbert 8 · CH

Funding

European Research Council 616830-MUSCLE_NETInnosuisse - Schweizerische Agentur für Innovationsförderung 44112.1 IP-LSKrebsforschung Schweiz KFS-3733-08-2015Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungSwiss Society for Research on Muscle DiseasesSystemsX.chUniversität Basel
6 · The paper itself

Abstract

backgroundInterventions to preserve functional capacities at advanced age are becoming increasingly important. So far, exercise provides the only means to counteract age-related decrements in physical performance and muscle function. Unfortunately, the effectiveness of exercise interventions in elderly populations is hampered by reduced acceptance and compliance as well as disuse complications. We therefore studied whether application of interleukin-6 (IL-6), a pleiotropic myokine that is induced by skeletal muscle activity and exerts broad systemic effects in response to exercise, affects physical performance and muscle function alone or in combination with training in aged mice.

methodsSedentary old male mice (Sed+Saline, n = 15) were compared with animals that received recombinant IL-6 (rIL-6) in an exercise-mimicking pulsatile manner (Sed+IL-6, n = 16), were trained with a moderate-intensity, low-volume endurance exercise regimen (Ex+Saline, n = 13), or were exposed to a combination of these two interventions (Ex+IL-6, n = 16) for 12 weeks. Before and at the end of the intervention, mice underwent a battery of tests to quantify endurance performance, muscle contractility in situ, motor coordination, and gait and metabolic parameters.

resultsMice exposed to enhanced levels of IL-6 during endurance exercise bouts showed superior improvements in endurance performance (33% more work and 12% greater peak power compared with baseline), fatigue resistance in situ (P = 0.0014 vs. Sed+Saline; P = 0.0199 vs. Sed+IL-6; and P = 0.0342 vs. Ex+Saline), motor coordination (rotarod performance, P = 0.0428), and gait (gait speed, P = 0.0053) following training. Pulsatile rIL-6 treatment in sedentary mice had only marginal effects on glucose tolerance and some gait parameters. No increase in adverse events or mortality related to rIL-6 treatment was observed.

conclusionsAdministration of rIL-6 paired with treadmill running bouts potentiates the adaptive response to a moderate-intensity low-volume endurance exercise regimen in old mice, while being safe and well tolerated.

Indexed as

Interleukin-6Physical Conditioning, AnimalRunningAnimalsMaleMiceMuscle, SkeletalPhysical EnduranceInterleukin-6AgeingExerciseFatigueFrailtyInterleukin-6MuscleMyokine

Identifiers

PMID35191221
PMCPMC8978011
OpenAlexW4213343860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.